|
AFF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.148760E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.531400E-01 |
| Normal-vs-Stage2 |
1.539440E-01 |
| Normal-vs-Stage3 |
2.669600E-02 |
| Normal-vs-Stage4 |
3.876400E-03 |
| Stage1-vs-Stage2 |
4.557000E-01 |
| Stage1-vs-Stage3 |
9.128400E-02 |
| Stage1-vs-Stage4 |
1.133810E-02 |
| Stage2-vs-Stage3 |
6.419200E-01 |
| Stage2-vs-Stage4 |
2.461400E-01 |
| Stage3-vs-Stage4 |
3.827000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.566100E-02 |
| Normal-vs-AfricanAmerican |
6.925600E-01 |
| Normal-vs-Asian |
2.442000E-01 |
| Caucasian-vs-AfricanAmerican |
7.846400E-02 |
| Caucasian-vs-Asian |
6.279400E-01 |
| AfricanAmerican-vs-Asian |
2.294200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.586000E-02 |
| Normal-vs-Female |
1.677590E-01 |
| Male-vs-Female |
4.880800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.348400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.020240E-01 |
| Normal-vs-Age(61-80Yrs) |
1.490120E-02 |
| Normal-vs-Age(81-100Yrs) |
7.741000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.317400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.344300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.832800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.087800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.611000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.832200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.90929999999545E-05 |
| Classical-VS-Follicular |
1.895410E-01 |
| Classical-VS-Other |
3.185000E-01 |
| Classical-VS-Normal |
1.715400E-01 |
| Tall-VS-Follicular |
7.98040000000722E-05 |
| Tall-VS-Other |
4.893000E-01 |
| Tall-VS-Normal |
3.79449999999837E-05 |
| Follicular-VS-Other |
3.133500E-02 |
| Follicular-VS-Normal |
9.915800E-01 |
| Other-VS-Normal |
1.032040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.309230E-01 |
| Normal-vs-N1 |
7.195500E-02 |
| N0-vs-N1 |
5.032200E-01 |
|
|
